LncRNA SNHG7 enhances the drug resistance of human acute myeloid leukemia cells through inhibiting miR-186

Abstract

Abstract: Objective To investigate the effect of long non-coding RNA (lncRNA) SNHG7 on cell drug resistance through inhibiting microRNA-186(miR-186). Methods Peripheral blood was taken from newly diagnosed AML patients, recurrent/refractory AML patients and healthy controls. AML adriamycin sensitive cells (HL60) and AML adriamycin resistant cells (HL60/ADM) were used to detect the expression of SNHG7 and miR-186 in peripheral blood and cell samples by fluorescence quantitative PCR. The sensitivity of HL60 and HL60/ADM cells to adriamycin was determined by CCK8 assay and the 50% inhibitory concentration(IC₅₀) was calculated. Sh-SNHG7 or miR-186 mimic or miR-186 inhibitor was transfected into HL60/ADM cells. The expres- sion of SNHG7 and miR-186 was detected by fluorescence quantitative PCR, the dose response and IC₅₀ of HL60/ADM to adriamycin were detected by CCK8. Double luciferase reporter gene assay was used to detect the targeted binding of SNHG7 to miR-186. Results The expression of SNHG7 in the serum of newly diagnosed AML and recurrent/refractory AML patients was significantly higher than that of normal controls, and the trend of miR-186 was contrary to that of SNHG7 (P＜0.01). Compared with HL60 cells, HL60/ADM cells were treated with adriamycin at different concentrations, and the IC₅₀ value of adriamycin on HL60/ADM (3.36±0.65) cells was significantly higher than that of HL60 cells (0.43±0.16) (P＜0.001). SNHG7 expression was significantly higher(P＜0.05) in HL60/ADM cells and miR-186 was significantly lower (P＜0.05). Transfection with sh-SNHG7 or miR-186 mimic in HL60/ADM cells increased the sensitivity to adriamycin and decreased the IC₅₀ value from 3.17±0.61 to 2.30±0.31 and 3.22±0.62 to 2.16±0.33, respectively (P＜0.05). Dual-luciferase reporter assay confirmed that SNHG7 could bind miR-186. Conclusions SNHG7 enhances drug resistance of AML cells during chemotherapy through inhibition of miR-186.

Key words: SNHG7, miR-186, proliferation, drug-resistance, acute myeloid leukemia

CLC Number:

R733.71

ZHU Juan, ZHOU Ying, LI Ying-jia. LncRNA SNHG7 enhances the drug resistance of human acute myeloid leukemia cells through inhibiting miR-186[J]. Basic & Clinical Medicine, 2021, 41(2): 171-177.

References

[1] Appelbaum FR, Rowe JM, Radich J, et al. Acute Myeloid Leukemia.[J]. N Engl J Med, 1999, 341:1051-1062.
[2] Cheng D,Fan J,Ma Y, et al. LncRNA SNHG7 promotes pancreatic cancer proliferation through ID4 by sponging miR-342-3p[J]. Cell Biosci,2019,9:22-28.
[3] Ren J, Yang Y, Xue J, et al. Long noncoding RNA SNHG7 promotes the progression and growth of glioblast-oma via inhibition of miR-5095[J]. Biochem Biophys Res Commun, 2018, 496:712-718.
[4] Cui G, Cui M, Li Y, et al. miR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells[J]. Tumour Biol, 2014, 35:8933-8937.
[5] Zhang TJ, Wang YX, Yang DQ, et al. Down-regulation of miR-186 correlates with poor survival in de novo acute myeloid leukemia[J]. Clin Lab, 2016, 62: 113-120.
[6] Lin P, Wen DY, Li Q, et al. Genome-wide analysis of prognostic lncRNAs, miRNAs, and mRNAs forming a competing endogenous RNA network in hepatocellular carcinoma[J]. Cell Physiol Biochem, 2018, 48: 1953-1967.
[7] Song L, Zhou Z, Gan Y, et al. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p[J]. J Cell Biochem, 2019, 120:9656-9666.
[8] Wang D, Zeng T, Lin Z, et al. Long non-coding RNA SNHG5 regulates chemotherapy resistance through the miR-32/DNAJB9 axis in acute myeloid leukemia[J]. Biomed Pharmacother, 2020. doi: 10.1016/j.biopha.2019.109802.
[9] Sun H, Sun Y, Chen Q, et al. LncRNA KCNQ1OT1 contributes to the progression and chemoresistance in acute myeloid leukemia by modulating Tspan3 through suppressing miR-193a-3p[J]. Life Sci, 2020. doi: 10.1016/j.lfs.2019.117161.
[10] Li Q, Song W, Wang J. TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2[J]. Biomed Pharmacother, 2019, 109:1793-1801.
[11] Li Y, Zeng C, Hu J, et al. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression[J]. J Hematol Oncol, 2018. doi: 10.1186/s13045-018-0632-2.
[12] Xia Q, Li J, Yang Z, et al. Long non-coding RNA small nucleolar RNA host gene 7 expression level in prostate cancer tissues predicts the prognosis of patients with prostate cancer[J]. Medicine (Baltimore), 2020. doi: 10.1097/MD.0000000000018993.
[13] Qin Y, Wang Y, Liu D. miR-4792 inhibits acute myeloid leukemia cells proliferation and invasion, and promotes cells apoptosis by targeting Kindlin-3[J]. Oncol Res, 2020. doi: 10.3727/096504020X15844389264424.
[14] Li H, Tian X, Wang P, et al. miR-582-3p negatively regulates cell proliferation and cell cycle progression in acute myeloid leukemia by targeting cyclin B2[J]. Cell Mol Biol Lett, 2019. doi: 10.1186/s11658-019-0184-7.

[1]	LIU Lei, LI Shi-bao, ZHANG Hao-liang. Lnc-SLC2A12-10:1 silencing inhibits the proliferation, migration and invasion of gastric cancer cell line AGS [J]. Basic & Clinical Medicine, 2022, 42(7): 1071-1076.
[2]	KANG You-li, ZHAO Dan, DU Wen-jing, LI Li. SIRT5 promotes the proliferation of human breast cancer cells by regulating the succinylation of ALDH5A1 [J]. Basic & Clinical Medicine, 2022, 42(7): 1099-1107.
[3]	BAI Bing, ZHANG Hai-fang, YANG Qing-liang, QIN Yue, ZHOU Chen-long, SONG Ge, WANG Ying. Down-regulation of lncRNA RHPN1-AS1 inhibits proliferation and migration of human bladder cancer cell line T24 [J]. Basic & Clinical Medicine, 2022, 42(6): 940-944.
[4]	SUN Quan-peng, FAN Chao, ZHAN De-xi, FAN Yi-ming, SUN Wei-feng. Ropivacaine inhibits proliferation, migration and invasion of human liver cancer cell line Hep3B [J]. Basic & Clinical Medicine, 2022, 42(3): 448-453.
[5]	ZHANG Jian, ZHANG Ji-jiong. LncRNA UNC5B-AS1 targeting miR-339-5p regulates the proliferation and apoptosis of human lung adenocarcinoma cell line A549 [J]. Basic & Clinical Medicine, 2022, 42(3): 454-460.
[6]	LIU Xin-bing, ZHANG Mei-hong. Gelsemine inhibits proliferation and invasion of rheumatoid arthritis synovial fibroblast through down-regulating circ_001680 [J]. Basic & Clinical Medicine, 2022, 42(3): 429-435.
[7]	ZHAO Xia, CAI Qing-chun, DING Rui-min, ZHANG Qian. Cinobufagin inhibits proliferation of human nasopharyngeal carcinoma cell lines CNE2 and HONE1 [J]. Basic & Clinical Medicine, 2022, 42(3): 436-440.
[8]	ZHANG Chun-li, QI Jie-hua, HUAN Yu, WU Shou-le, CAI Xu-shan. Interference with ADAM17 inhibits proliferation of human cervical cancer cell line HeLa [J]. Basic & Clinical Medicine, 2022, 42(2): 255-259.
[9]	WANG Bu, YUAN Sheng-fang, ZHANG Chang-hong, YUAN Cheng, HUANG Pan-deng, ZHANG Zhi-hua, ZHAO Jian-qing. Silencing eEF2K combined with sodium tanshinone ⅡA sulfonate synergistically inhibit proliferation of human lung adenocarcinoma cell line A549 [J]. Basic & Clinical Medicine, 2022, 42(1): 106-113.
[10]	LI Yong-xiao, SUN Yan, ZHANG Rui-sheng. Propofol inhibits proliferation of human endometrial cancer cell line RL95-2 [J]. Basic & Clinical Medicine, 2022, 42(1): 114-119.
[11]	WANG Ling-xia, YAN Yu-lan, YUAN Hai-tao, CAI Ye-wei, LIU De-hui, GU Wen-lu, CAO Bi-yue. CircRNA_23113 inhibits the proliferation and migration of lung adenocarcinoma cells [J]. Basic & Clinical Medicine, 2022, 42(1): 82-88.
[12]	SHI Tie-wei, LI Tian-zhu, ZHOU Jing, NA Ri-su, SUN Qi, XU Li-yan, BAI Chun-ying. Effects of 5-lipoxygenase activating protein inhibitor MK886 on proliferation and apoptosis of human esophageal cancer cell lines [J]. Basic & Clinical Medicine, 2022, 42(1): 56-61.
[13]	. Establishment of a serum-free culture method for human amnion mesenchymal stem cells [J]. Basic & Clinical Medicine, 2021, 41(8): 1181-1185.
[14]	. Up-regulation of miR-433 expression inhibits proliferation of colorectal cancer cell line in vitro [J]. Basic & Clinical Medicine, 2021, 41(8): 1127-1132.
[15]	. Zerumbone inhibits the proliferation, migration and invasion of human non-small cell lung cancer cell line A549 through up-regulating FBXW7 expression [J]. Basic & Clinical Medicine, 2021, 41(8): 1163-1168.